BIOMAT Database Logo BIOMAT Database Logo

[Use of prodigiozan in chronic diseases of intestine]. 1969

N I Ekisenina, and T I Kudinova, and G E Vaĭsberg, and L M Ivanova, and L P Miagkova

UI MeSH Term Description Entries
D008297 Male Males
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003092 Colitis Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER. Colitides
D004035 Diet Therapy Adjusting the quantity and quality of food intake to improve health status of an individual. This term does not include the methods of food intake (NUTRITIONAL SUPPORT). Diet Therapy, Restrictive,Dietary Modification,Dietary Restriction,Restriction Diet Therapies,Restriction Diet Therapy,Restrictive Diet Therapies,Restrictive Diet Therapy,Diet Modification,Therapy, Diet,Diet Modifications,Diet Therapies,Diet Therapies, Restriction,Diet Therapy, Restriction,Dietary Modifications,Dietary Restrictions,Modification, Diet,Modification, Dietary,Restriction, Dietary,Therapy, Restriction Diet,Therapy, Restrictive Diet
D004751 Enteritis Inflammation of any segment of the SMALL INTESTINE. Enteritides
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

N I Ekisenina, and T I Kudinova, and G E Vaĭsberg, and L M Ivanova, and L P Miagkova
[Use of prodigiozan for treating chronic pyelonephritis].
June 1972, Terapevticheskii arkhiv,
N I Ekisenina, and T I Kudinova, and G E Vaĭsberg, and L M Ivanova, and L P Miagkova
[Use of prodigiozan and lysozyme in ENT organ diseases].
January 1980, Zhurnal ushnykh, nosovykh i gorlovykh boleznei = The journal of otology, rhinology, and laryngologie [sic],
N I Ekisenina, and T I Kudinova, and G E Vaĭsberg, and L M Ivanova, and L P Miagkova
[Use of prodigiozan in chronic hematogenous osteomyelitis in children].
July 1985, Khirurgiia,
N I Ekisenina, and T I Kudinova, and G E Vaĭsberg, and L M Ivanova, and L P Miagkova
[Experience in the use of prodigiozan in the treatment of chronic inflammatory diseases of the female reproductive organs].
December 1967, Akusherstvo i ginekologiia,
N I Ekisenina, and T I Kudinova, and G E Vaĭsberg, and L M Ivanova, and L P Miagkova
[Effectiveness of prodigiozan in the therapy of chronic nonspecific diseases of the lungs].
February 1975, Antibiotiki,
N I Ekisenina, and T I Kudinova, and G E Vaĭsberg, and L M Ivanova, and L P Miagkova
[Protein hydrolysates and their use in chronic diseases of the intestine].
March 1961, Terapevticheskii arkhiv,
N I Ekisenina, and T I Kudinova, and G E Vaĭsberg, and L M Ivanova, and L P Miagkova
[Use of prodigiozan for preventing acute respiratory viral diseases in a children's collective].
February 1978, Antibiotiki,
N I Ekisenina, and T I Kudinova, and G E Vaĭsberg, and L M Ivanova, and L P Miagkova
[Use of polysaccharide prodigiozan in the complex therapy of chronic and residual brucellosis].
June 1971, Antibiotiki,
N I Ekisenina, and T I Kudinova, and G E Vaĭsberg, and L M Ivanova, and L P Miagkova
[Differential use of preformed physical factors in prodigiozan treatment of chronic salpingo-oophoritis].
January 1987, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
N I Ekisenina, and T I Kudinova, and G E Vaĭsberg, and L M Ivanova, and L P Miagkova
[Experience in the use of prodigiozan in the treatment of chronic bronchitis in miners].
June 1969, Antibiotiki,
Copied contents to your clipboard!